Literature DB >> 16159687

Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan.

Sheng-Nan Lu1, Chien-Hung Chen, Tsung-Ming Chen, Pei-Lun Lee, Jing-Houng Wang, Hung-Da Tung, Chao-Hung Hung, Chuan-Mo Lee, Chi-Sin Changchien.   

Abstract

In Taiwan, decrease of both infection and carrier rates of hepatitis B virus (HBV) have been documented especially in metropolitan areas after universal HBV vaccination. This study investigated HBV infection status in a rural township 15 years after the program began. Three cross-sectional studies were conducted in 1999, 2000 and 2003, to recruit all the students of the only junior middle school, born from July 1984 to June 1991, in a township in central Taiwan. Serum samples were tested for HBsAg, anti-HBs and anti-HBc. Subjects identified to be neither positive for HBsAg nor anti-HBs were given a booster dose of HBV vaccine. Subjects lacking an anamnestic anti-HBs response were given a complete 3-dose vaccination. A total of 1454 (98.5%) students responded. The prevalence rate of HBsAg decreased 57% [from 12.5% in 1984 to 5.4% in 1991, P < 0.005 (chi2-test for linear trends)], and anti-HBc positive rate dropped 68% (from 31.9 to 10.2%, P < 0.001). An anamnestic anti-HBs response developed after a vaccine booster among 433 (72%) anti-HBs negative and 12 (66.7%) anti-HBc alone subjects. And 93 (94.9%) anti-HBs negative and 1 (16.7%) anti-HBc alone subject developed a primary anti-HBs response after catch-up vaccination. Viremia was detected for two anti-HBc alone subjects without anamnestic or primary response. The vaccination program has decreased the number of those infected and carrier rates in either urban or rural areas in Taiwan. However, the prevalence of HBsAg and anti-HBc in rural area were much higher than urban area.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16159687     DOI: 10.1016/j.vaccine.2005.08.062

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

Review 1.  Epidemiology of hepatitis B--clinical implications.

Authors:  Jacob Alexander; Kris V Kowdley
Journal:  MedGenMed       Date:  2006-04-13

2.  HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy.

Authors:  T-W Wu; C-C Chu; H-W Chang Liao; S-K Lin; T-Y Ho; M Lin; H H Lin; L-Y Wang
Journal:  Genes Immun       Date:  2013-11-28       Impact factor: 2.676

3.  Responses to booster hepatitis B vaccination are significantly correlated with genotypes of human leukocyte antigen (HLA)-DPB1 in neonatally vaccinated adolescents.

Authors:  Tzu-Wei Wu; Chen-Chung Chu; Tzu-Ying Ho; Huei-Wen Chang Liao; Sheng-Kai Lin; Marie Lin; Hans Hsienhong Lin; Li-Yu Wang
Journal:  Hum Genet       Date:  2013-06-06       Impact factor: 4.132

4.  The effects of booster vaccination of hepatitis B vaccine on children 5-15 years after primary immunization: A 5-year follow-up study.

Authors:  Zikang Wu; Jun Yao; Hongdan Bao; Yongdi Chen; Shunshun Lu; Jing Li; Linna Yang; Zhenggang Jiang; Jingjing Ren; Kai-Jin Xu; Bing Ruan; Shi-Gui Yang; Tian-Sheng Xie; Qian Li
Journal:  Hum Vaccin Immunother       Date:  2018-02-26       Impact factor: 3.452

5.  Universal vaccination and thereafter.

Authors:  Toshiji Saibara
Journal:  J Gastroenterol       Date:  2006-04       Impact factor: 6.772

6.  Early detection of unhealthy behaviors, the prevalence and receipt of antiviral treatment for disabled adult hepatitis B and C carriers.

Authors:  Sui-Whi Jane; Ming-Shyan Lin; Wen-Nan Chiu; Li-Ju Lai; Po-Han Chen; Mei-Yen Chen
Journal:  BMC Public Health       Date:  2016-02-13       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.